Supernova 2

Supernova Invest, established in 1999, is a Paris-based private equity and venture capital firm with additional offices in Grenoble. It manages a €800m fund, Supernova 2, founded in 2017. The firm specializes in early-stage investments, focusing on deep technology companies across sectors such as healthcare, industry 4.0, energy & environment, and digital technologies. It provides patient capital and expertise to support high-growth startups, with a track record of successful exits through IPOs and M&As. Supernova Invest partners with CEA Investissement to offer startups access to the CEA network and services.

Cécile Benet

Investment Director

Lucille Benoît

Analyst

Alexandre Biau

Investment Director

Alexandre Biau

Investment Director

Damien Bretegnier

Investment Director

Carole Cazassus

Investment Director

Pascal-André Chenal

Investment Manager

Alexandre Cordier

Analyst

Arthur Falinower

Analyst

Marine Glon

Investment Director

Celia Hart

General Partner

Claude-Sebastien Lerbourg

Investment Director

Etienne Moreau

Partner

Arthur Puig

Associate

Regis Saleur

Managing Partner

Romain Sautrau

Investment Director

Remi Spagnol

Investment Director

Pierre-Emmanuel Struyven

Managing Partner

Michaël Thomas

Partner

Michael Thomas

Investment Director

Nicolas Topuz

Analyst

Gregoire Viot

CFO

Pascal-andré Chenal

Investment Director

Claude-Sebastien Lerbourg

Investment Director

82 past transactions

mirSense

Series A in 2025
mirSense SA is a French company specializing in the development and manufacturing of Quantum Cascade Lasers (QCL) and QCL-based spectrometer modules. Established in 2015 and headquartered in Palaiseau, the company offers a range of products including uniMir, a single mode QCL for high spectral purity; multiMir, a semiconductor solution for broadband tuning; multiSense, a spectrometer module designed for gas analyzer manufacturers; and powerMir, power lasers tailored for defense and security applications. These technologies are aimed at enhancing air quality, reducing greenhouse gas emissions, ensuring process sustainability, and improving the accuracy of medical treatments. By providing ultra-compact gas sensors with very low detection limits, mirSense supports industries and defense sectors in monitoring gas emissions, detecting hazardous substances, and analyzing biological samples with affordability and high performance.

Galam Robotics

Series A in 2025
Galam Robotics specializes in modular robotic solutions aimed at enhancing logistics and storage processes. The company develops innovative robotics technology that significantly increases productivity and efficiency in various trades and urban logistics. By transforming storage capabilities within constrained spaces, Galam Robotics enables clients to optimize their storage capacity while maximizing input and output flows. This focus on modularity allows for tailored solutions that meet diverse operational needs, making it easier for businesses to adapt to changing demands in logistics and storage management.

Fyteko

Series B in 2025
Fyteko is an agtech company based in Brussels, Belgium, founded in 2014. The company specializes in the development and production of advanced bio-stimulants designed to enhance plants' resistance to abiotic stress, such as drought and extreme temperatures. Fyteko focuses on creating bio-based technologies that aim to improve crop productivity and quality while addressing the environmental impact of agriculture. Its innovative biostimulant biomolecule allows plants to better withstand both biotic and abiotic stresses, supporting farmers in their efforts to cultivate resilient and high-quality crops.

Enduro Genetics

Series A in 2025
Enduro Genetics is a technology provider that specializes in enhancing large-scale fermentations through its proprietary synthetic biology technology. The company focuses on improving the performance of fermentation processes by developing a genetic plugin technology that is free of antibiotic resistance genes. This innovation allows for higher yields by enriching spontaneous high producers within the fermentation population, facilitating the production of complex or cellular inhibit products by addressing strain instability. By maximizing the performance of cells derived from production strains, Enduro aims to bolster the competitiveness of both current and future green bioproduction initiatives.

Alice & Bob

Series B in 2025
Alice & Bob is a Paris-based company founded in 2020 that specializes in the manufacture of universal, error-free quantum computers. The company’s innovative technology features self-correcting superconducting quantum bits, which provide fault-tolerant capabilities and allow for the execution of any quantum algorithm. By offering these advanced computing solutions, Alice & Bob aims to assist industries and researchers in tackling complex problems that require quantum computing power.

Capra Robotics

Seed Round in 2025
Capra Robotics is a research engineering company that specializes in the development of mobile robots aimed at enhancing outdoor mobility. The company has patented a versatile platform designed for outdoor use, allowing for mobility in various terrains. Its electric mobility device is user-friendly, portable, and maneuverable, making it suitable for both indoor and outdoor environments. This innovation is particularly beneficial for inactive and physically challenged individuals, as it facilitates their movement and improves their quality of life.

Loft Orbital

Series C in 2025
Loft Orbital Solutions Inc. is a company based in San Francisco, California, that provides comprehensive services for the deployment and operation of customer payloads in space. Established in 2017, Loft Orbital specializes in operating microsatellites and offers an end-to-end solution that includes satellite platform integration, launch booking, and operational management. The company simplifies the satellite deployment process by utilizing a standardized satellite bus and a suite of software tools, thereby reducing costs and accelerating the timeline to orbit. Additionally, Loft Orbital addresses financial and regulatory challenges by providing solutions for licensing, insurance, and financing, allowing customers to concentrate on their mission objectives rather than the technical complexities of satellite engineering.

ANYbotics

Series B in 2024
ANYbotics AG, founded in 2016 and based in Zurich, Switzerland, specializes in developing autonomous, legged robots designed for industrial applications. The company focuses on creating innovative robotic solutions that enhance worker safety and productivity while promoting sustainable industrial practices. ANYbotics' robots are equipped with advanced features such as docking stations, sensing capabilities, and waterproof designs, enabling them to perform various tasks, including routine inspections, asset monitoring, gas detection, and the creation of 3D models. Their technology is particularly beneficial for industries like oil and gas, power, energy, mining, processing, chemicals, transportation, and construction, where complex and hazardous environments require reliable inspection solutions. With a team of over 100 employees, ANYbotics collaborates with global technology leaders to deliver integrated robotic systems that support the operational needs of large asset operators.

Dessia

Venture Round in 2024
Dessia is a technology company that specializes in AI-augmented engineering software. Its platform employs bots to assist engineers and architects in designing mechanical systems, swiftly generating thousands of architectural configurations and optimizing them based on sustainability and profitability criteria. This streamlines the product development process, reducing lead times for automotive and mechanical engineers.

Discure

Series A in 2024
Discure Technologies is focused on developing a minimally invasive, implantable bioelectronic device aimed at treating degenerative disc disease (DDD). The company employs a novel bioelectric technique that targets the root causes of DDD, facilitating the healing of damaged discs, alleviating pain, and restoring normal function for patients. Through its innovative approach, Discure seeks to provide effective solutions for individuals suffering from this debilitating condition.

Wattalps

Series A in 2024
Wattalps is a technology company specializing in the development of lithium power systems tailored for small and medium-scale applications. Their product portfolio focuses on affordability, passive safety measures, efficient cooling mechanisms, extended lifespan, and robust cell protection features. Wattalps aims to simplify integration into vehicles or charging stations by offering standard and modular products, thereby facilitating swift, efficient, and cost-effective adoption of electric vehicle technologies and sustainable transportation solutions.

Micropep

Series B in 2024
Micropep Technologies is an agricultural biotechnology company founded in 2016 and based in Toulouse, France. The company specializes in the development of non-GMO bioherbicides and biostimulants utilizing its innovative miPEP technology, which harnesses naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep focuses on four key development programs: germination, flowering, growth, and weed control, aiming to improve agricultural yields while maintaining the integrity of plant DNA. By leveraging the potential of these biomimetic peptides, Micropep seeks to provide effective solutions for managing plant genetics and enhancing resistance to diseases, thereby supporting sustainable farming practices.

UroMems

Series C in 2024
UroMems is a medical device company dedicated to addressing specific clinical needs related to urinary conditions that significantly impact patients' quality of life. The company specializes in the design, development, and commercialization of active implantable medical devices. Its innovative approach aims to enhance existing surgical treatments by minimizing associated side effects and ensuring that patients receive appropriate care promptly. Through its commitment to improving treatment options, UroMems seeks to benefit a wide range of patients facing urinary health challenges.

Seederal

Series A in 2024
Seederal Technologies is a manufacturer specializing in agriculture, construction, and mining machinery, with a focus on innovative medium-power electric tractors. The company designs tractors that deliver 160 horsepower using electric motors, aiming to minimize the environmental impact associated with traditional agricultural equipment. By providing a more sustainable option, Seederal seeks to reduce the overall cost of ownership for farmers, allowing them to benefit from the efficiency and autonomy of electric tractors while maintaining the power equivalent to conventional models.

Diabeloop

Venture Round in 2024
Diabeloop is a medical device company based in Grenoble, France, specializing in innovative solutions for diabetes management. Founded in 2015, the company focuses on developing a closed-loop system that automates insulin delivery for individuals with type 1 diabetes. Its AI-based blood sugar monitoring device integrates a sensor that continuously measures glucose levels, a pump that administers insulin, and a smartphone application that connects these components through an embedded algorithm. This technology aims to enhance the treatment experience by reducing the mental burden on patients, allowing them to manage their condition more effortlessly and live their lives with greater freedom.

Wise Integration

Series B in 2024
Developer of generative adversarial network integrated circuits and digital control specializing in power electronics based on gallium nitride technology designed to miniaturize power supplies and improve energy efficiency. The company's product can be used in chargers, power supplies for e-mobility, industrial applications, personal computer chargers, and data centers as well as offers efficiency and high-power-density alternating current and direct current converters and reliability for better usage, enabling clients to optimize system integration with reduced cost and size.

Unseenlabs

Series C in 2024
Unseenlabs is a French company founded in 2015 and headquartered in Rennes, Brittany, specializing in marine surveillance services. The company designs and develops advanced spectrum surveillance payloads that enable the detection and tracking of non-cooperative vessels worldwide. Unseenlabs offers comprehensive solutions that encompass satellite design, deployment, and operational support. By launching satellites that can detect and geolocate signals and electromagnetic waves emitted by ships, Unseenlabs provides clients with the capability to monitor maritime activities, even when vessels disable their Automatic Identification System beacons. This technology is particularly valuable for identifying illegal operations such as fishing violations, degassing, and maritime piracy.

Cambridge Mechatronics

Venture Round in 2024
Cambridge Mechatronics Ltd. is a technology design and engineering company based in Cambridge, United Kingdom, specializing in the development of innovative mechatronic systems for the mobile phone and consumer electronics markets. Established in 1995, the company has pioneered the use of Shape Memory Alloy technology to create miniature actuators for various applications, including optical image stabilization (OIS) systems that enhance smartphone camera capabilities. Its product offerings include OIS actuators, AutoFocus actuators for high-resolution cameras, Dynasonix 3D audio products, and Digital Sound Projectors that manipulate sound directionality. Cambridge Mechatronics holds an extensive intellectual property portfolio with over 100 granted patents, enabling it to partner with global manufacturers for technology licensing and mass production.

Vulkam

Venture Round in 2023
Vulkam SAS is a microtechnology company based in Saint-Martin-d'Hères, France, specializing in the design and production of amorphous metal parts. Founded in 2017, Vulkam focuses on creating biocompatible amorphous metal alloys primarily composed of zirconium, copper, hafnium, nickel, and titanium. The company's innovative products serve various industries, including aerospace, automotive, biomedical, and microcomponents. Vulkam's micromechanical parts are notable for their small size and exceptional strength, offering performance comparable to established industry standards. By leveraging advanced materials science, Vulkam aims to set new benchmarks in metallurgy and metal processing, catering to the growing demand for high-performance, functional components in diverse applications.

Carthera

Series B in 2023
Carthera is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices for treating brain disorders. Its proprietary device, SonoCloud®, is an intracranial ultrasound implant that, when used in conjunction with an intravenous microbubble agent, temporarily opens the blood-brain barrier. This mechanism significantly enhances the delivery of therapeutic molecules to the brain, potentially providing new treatment options for debilitating neurological conditions. Through its technology, Carthera aims to enable healthcare professionals to address challenging brain disorders more effectively.

Adionics

Series B in 2023
Adionics is a technology company based in Paris, France, specializing in desalination and saline water valorization. Founded in 2012, the company develops innovative solutions to selectively remove salts from brine, seawater, and other salty waters. Its flagship technology, AquaOmnes, effectively separates salt from water, while Flionex is a selective extractant composition designed for the extraction of lithium salts. Adionics focuses on providing its services to various sectors, including municipal water, power, oil and gas, and chemicals. The company is also engaged in research and development to enhance its processes, particularly in the area of lithium recycling from batteries, aiming to deliver efficient, economical solutions with minimal environmental impact.

EODev

Series A in 2023
EODev is a company focused on accelerating the energy transition through innovative hydrogen generation technology. The firm develops a range of products and services aimed at providing sustainable and efficient energy solutions. Their offerings include an energy designer, a hydrogen generator, and a navigation range extender, all of which enable various sectors to access clean and renewable energy alternatives to fossil fuels. By promoting the use of hydrogen as an energy source, EODev is committed to creating dependable and cost-effective solutions that support the transition towards a more sustainable energy landscape.

Aledia

Venture Round in 2023
Aledia SA, established in 2011, specializes in the development and manufacturing of light-emitting diodes (LEDs). The company's proprietary technology involves a 3D architecture using gallium-nitride-on-silicon microwires, enabling cost-effective production of LED chips at 25% the cost of traditional planar LED chips. Aledia's products cater to general lighting, automotive, and display applications, with a focus on mobile displays and microdisplays for AR/VR devices. Headquartered in Grenoble, France, the company has subsidiaries in Malacca, Malaysia, and Palo Alto, California.

Quobly

Seed Round in 2023
Quobly is a developer of quantum computing semiconductors focused on creating and marketing a universal large-scale quantum computer. By utilizing established semiconductor industry procedures, the company aims to commercialize quantum computers based on silicon. Quobly's technology is designed to address complex problems, such as optimizing energy distribution and computing chemical properties, which can accelerate the development of new drugs. The company provides clients with customized quantum computing solutions that leverage proven semiconductor processes to meet their specific needs.

Allotex

Series B in 2023
Allotex, Inc. is an ophthalmic biologics and device company based in Boston, Massachusetts. Founded in 2013, it specializes in the development of innovative contact lenses and therapeutic solutions aimed at addressing refractive vision issues such as presbyopia, hyperopia, and myopia. Allotex utilizes precisely-shaped human corneal allografts in conjunction with a compact excimer laser system to create permanent, living contact lenses or lens inserts. This approach allows medical professionals to provide the least invasive treatment options for various refractive procedures, enhancing patient outcomes in vision correction.

Gleamer

Series B in 2023
Gleamer is a company specializing in artificial intelligence-based solutions for radiology, focusing on enhancing diagnostic accuracy for medical imaging. By integrating its AI companions into the existing reading environments of radiologists, Gleamer provides an automated second reading that aids in the detection of bone abnormalities, lesions, and other critical details in X-ray images. This technology not only improves efficiency but also helps ensure that all patients receive accurate diagnoses. Currently, Gleamer's solutions are utilized in over 300 institutions across 13 countries, demonstrating its commitment to advancing radiological practices and supporting medical professionals in prioritizing patient care.

Carthera

Series B in 2023
Carthera is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices for treating brain disorders. Its proprietary device, SonoCloud®, is an intracranial ultrasound implant that, when used in conjunction with an intravenous microbubble agent, temporarily opens the blood-brain barrier. This mechanism significantly enhances the delivery of therapeutic molecules to the brain, potentially providing new treatment options for debilitating neurological conditions. Through its technology, Carthera aims to enable healthcare professionals to address challenging brain disorders more effectively.

BeFC Bioenzymatic Fuel Cells

Series A in 2023
BeFC Bioenzymatic Fuel Cells is a company based in Grenoble, France, that specializes in the development of ecological devices, specifically paper-based bioenzymatic fuel cells. Founded in 2020, BeFC focuses on providing sustainable and eco-friendly energy solutions aimed at minimizing environmental impact. Their innovative technology features ultra-thin, flexible, and miniature fuel cells designed to replace traditional button or coin cell batteries, which are often difficult to recycle and environmentally harmful. By offering a safe alternative, BeFC facilitates the advancement of disposable and wearable medical devices, as well as low-power applications in health monitoring, logistics, and the Internet of Things (IoT). The company's approach not only addresses existing energy needs but also opens up new opportunities in various sectors.

ProovStation

Series A in 2023
ProovStation is a DeepTech start-up that operates in 13 European countries, focusing on automating and standardizing the automotive inspection process through advanced computer vision technology. Established in 2017, the company aims to enhance efficiency and reduce costs associated with vehicle inspections. ProovStation has developed a series of high-tech vehicle scanners that perform a 360-degree scan of vehicles in just three seconds, utilizing an array of optical technologies to analyze damages down to a millimeter scale. The system employs artificial intelligence to detect, measure, and locate these damages, generating a secure, time-stamped, and geolocated report. In addition to the inspection technology, ProovStation offers customers a suite of software-as-a-service solutions, including automatic reconditioning quotes, vehicle pricing for resale, and various management tools designed to streamline the inspection and reconditioning processes.

SoniVie

Series C in 2023
SoniVie is a medical device company focused on developing innovative solutions for the treatment of pulmonary hypertension. The company has created a minimally invasive denervation device that is designed to be inserted into the pulmonary artery through a catheterization procedure. This advanced technology selectively targets and damages the nerves associated with pulmonary hypertension, while preserving the integrity of the vessel walls and surrounding tissues. By enabling physicians to perform denervation procedures with greater precision, SoniVie aims to improve treatment options and outcomes for patients suffering from this serious condition.

Remedee Labs

Series A in 2022
Remedee Labs SAS is a French company founded in 2016, dedicated to developing innovative solutions for chronic pain management. The company has created the Microelectronic Endorphin Trigger (MEET), a personal endorphin stimulator that facilitates on-demand stimulation of the body’s natural endorphins to alleviate pain. Drawing on a decade of pre-clinical and clinical research, Remedee Labs aims to improve the quality of life for the 1.5 billion people worldwide suffering from chronic pain, particularly focusing on conditions such as fibromyalgia. By collaborating with medical practitioners, the company offers a patient-centered digital service platform that enhances the accessibility and effectiveness of endorphin-stimulation therapy for personal healthcare. As it continues to evolve, Remedee Labs plans to expand its platform to address additional chronic pain conditions, positioning itself as a leader in neuromodulation technology for pain management.

Aniah

Series A in 2022
Aniah is a company that specializes in providing an integrated circuit (IC) verification tool designed to eliminate electrical errors in chip designs. The platform conducts electrically accurate analyses at the transistor level, allowing for the detection of errors across the entire IC in a single run. This capability enables users to focus on correcting genuine errors rather than sifting through false positives, thereby enhancing the efficiency of the design process. Aniah's technology delivers relevant results in seconds, facilitating continuous design improvements and expediting the sign-off process for semiconductor projects. By integrating this verification tool, companies and engineers can maintain a higher level of accuracy and vigilance during complex workflow scenarios.

CrowdSec

Series A in 2022
CrowdSec is an open-source cybersecurity platform that specializes in analyzing visitor behavior to enhance online security. The company’s software provides real-time threat detection and security automation, allowing users to respond effectively to various types of attacks. By leveraging a community-driven approach, CrowdSec enables its users to share information about blocked IP addresses, thereby enhancing collective security measures across the internet. Its focus on behavior analysis and data breach prevention positions CrowdSec as a valuable resource for organizations seeking to protect their digital assets from emerging threats.

Prophesee

Series C in 2022
Prophesee SA, founded in 2014 and based in Paris, France, specializes in developing advanced machine vision sensors and systems. Renowned for its neuromorphic vision technology, the company has created a unique visual processing platform that mimics human vision by detecting events rather than capturing sequences of images. This innovative Metavision® approach enables significant advancements in speed, dynamic range, data efficiency, and power consumption, making it suitable for a variety of applications including autonomous driving, mobile devices, industrial automation, and security systems. Prophesee serves a diverse clientele across multiple sectors such as biomedical, gaming, robotics, and aerospace. The company boasts a team of over 100 engineers and holds more than 50 international patents, positioning itself as a leader in next-generation vision technologies.

Moments Lab

Series A in 2022
Moments Lab is a technology company focused on enhancing the efficiency of content production, particularly in video creation. Its platform utilizes MXT Multimodal AI to make audiovisual content searchable, which significantly reduces the time needed for content producers to identify and source key moments for storytelling. By offering solutions such as Just Index for metadata extraction, Media Hub for advanced media asset management, Live Asset Manager for real-time access to live streams, and Media Marketplace for monetizing media libraries, Moments Lab caters to a diverse clientele, including TV networks, sports rights holders, and journalists. The platform enables organizations to improve productivity by streamlining the video sourcing process, providing immediate access to valuable content, and generating new revenue opportunities. With a commitment to making media assets more accessible and reusable, Moments Lab serves a global market, enhancing the workflow of content professionals and helping them focus on creative tasks.

Micropep

Series A in 2022
Micropep Technologies is an agricultural biotechnology company founded in 2016 and based in Toulouse, France. The company specializes in the development of non-GMO bioherbicides and biostimulants utilizing its innovative miPEP technology, which harnesses naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep focuses on four key development programs: germination, flowering, growth, and weed control, aiming to improve agricultural yields while maintaining the integrity of plant DNA. By leveraging the potential of these biomimetic peptides, Micropep seeks to provide effective solutions for managing plant genetics and enhancing resistance to diseases, thereby supporting sustainable farming practices.

Scintil Photonics

Venture Round in 2022
Scintil Photonics SAS is a company based in Grenoble, France, that specializes in the development of silicon photonic integrated circuits. Founded in 2018, the company offers a range of products, including laser integration, multi-wavelength lasers, waveguides, wavelength filters, and photodetectors. Scintil Photonics employs a unique approach by combining silicon and indium phosphide materials through wafer-scale bonding, utilizing commercial silicon foundry processes to create fully integrated photonic circuits. These circuits are designed to enhance high-speed optical communications and chip interconnections, providing a single-chip solution that integrates optical amplifiers and lasers with silicon modulators and germanium photodetectors. This innovative technology improves performance and reliability while significantly reducing implementation costs across various industries.

Diabeloop

Series C in 2022
Diabeloop is a medical device company based in Grenoble, France, specializing in innovative solutions for diabetes management. Founded in 2015, the company focuses on developing a closed-loop system that automates insulin delivery for individuals with type 1 diabetes. Its AI-based blood sugar monitoring device integrates a sensor that continuously measures glucose levels, a pump that administers insulin, and a smartphone application that connects these components through an embedded algorithm. This technology aims to enhance the treatment experience by reducing the mental burden on patients, allowing them to manage their condition more effortlessly and live their lives with greater freedom.

UnitySC

Venture Round in 2022
UnitySC is a globally recognized leader in inspection and metrology, specializing in advanced technologies such as automated optical inspection and 3D imaging. By offering customized solutions tailored to specific industrial requirements, UnitySC empowers customers to enhance yields and accelerate time to market. Through innovative techniques like high depth of focus line scanning and spectrometry, UnitySC enables a new era in process control, facilitating efficient and precise manufacturing operations.

Cairdac

Series A in 2022
Cairdac is a medical technology startup specializing in the development of innovative cardiac pacing systems. The company's flagship product is ALPS™, a self-sustaining, leadless pacemaker powered by a proprietary piezoelectric energy harvester that converts heart motion into electrical energy. This unique power source enables ALPS™ to have an extended lifespan of over 15 years, reducing the need for battery replacements and improving patient outcomes. Cairdac's mission is to provide cost-effective, disruptive solutions to traditional pacing systems, enhancing patients' quality of life and addressing growing healthcare needs.

Terakalis

Series A in 2022
Terakalis is a company that specializes in the development of non-destructive testing equipment for the analysis and control of materials and industrial processes. Established through a technological partnership with the Charles Coulomb laboratory in 2012, Terakalis focuses on TeraHertz electromagnetic waves, which range from 100 GHz to 10 THz. The company's offerings include a variety of both generic and custom-made products and systems designed to inspect materials for internal defects and to characterize their physical and chemical properties. By providing integrated line-of-production equipment and portable alternatives, Terakalis enhances operational efficiency for businesses across various sectors.

Alice & Bob

Series A in 2022
Alice & Bob is a Paris-based company founded in 2020 that specializes in the manufacture of universal, error-free quantum computers. The company’s innovative technology features self-correcting superconducting quantum bits, which provide fault-tolerant capabilities and allow for the execution of any quantum algorithm. By offering these advanced computing solutions, Alice & Bob aims to assist industries and researchers in tackling complex problems that require quantum computing power.

Aleph Zero

Seed Round in 2022
Aleph Zero is a developer of a peer-reviewed distributed ledger platform designed to address the limitations of existing blockchain infrastructures across various industries. The platform utilizes a proof-of-stake consensus mechanism and features a directed acyclic graph (DAG) architecture, ensuring high speed and scalability. Aleph Zero incorporates privacy-enhancing capabilities based on secure multi-party computation research, allowing developers to innovate without technological constraints. Its ecosystem supports smart contracts and includes a universally trustless wallet, facilitating seamless interactions with other blockchains. The company aims to promote the mass adoption of distributed ledger technology through its advanced and developer-friendly offerings.

Traxens

Venture Round in 2022
Traxens is a provider of supply chain tracking services that offers comprehensive data and analytics to enhance visibility into container transport and logistics. The company focuses on delivering precise and timely information on containers and their transporters, enabling stakeholders in multi-modal transport to improve operational efficiency, reduce costs, and optimize investments. Through a dedicated three-year research and development program, Traxens has developed advanced technology for cost-effective, durable, and autonomous devices capable of capturing and transmitting real-time data from anywhere in the world. This innovative approach allows Traxens to transform logistics data into actionable insights, benefiting a wide range of customers in the supply chain industry.

NAWA Technologies

Series C in 2022
NAWA Technologies specializes in developing advanced energy storage solutions, focusing on its innovative Ultra Fast Carbon Battery Technology. Founded in April 2013 and supported by over 15 years of research and development in nanomaterials, the company aims to enhance energy conversion, storage, transport, and efficiency using carbon, which is abundant and environmentally friendly. NAWA Technologies creates ultracapacitors and battery electrodes that facilitate the integration of renewable energies into smart grids, thus promoting more efficient and sustainable electricity storage. The company is committed to minimizing the environmental impact of its manufacturing processes and emphasizes the importance of reusing, recovering, and recycling materials throughout the product lifecycle. With a dedicated team of 24 employees, NAWA Technologies operates a pilot production line to innovate new interface materials and storage devices that reduce carbon emissions and reliance on fossil fuels.

iFollow

Series A in 2021
iFollow is a manufacturer of collaborative autonomous robots designed to enhance operations in the logistics and retail sectors. The company specializes in developing autonomous mobile robots (AMRs) that automate the transport of heavy loads, addressing needs across various industries, including food, industrial, pharmaceutical, chemical, cosmetics, logistics, and retail. iFollow also offers a proprietary software suite that facilitates the optimization of intralogistics flows, enabling clients to improve productivity and efficiency in their operations. Through its innovative solutions, iFollow aims to transform traditional logistics processes by integrating advanced robotics technology.

CORE for Tech

Venture Round in 2021
Core for Tech is a deep technology company dedicated to enhancing road safety by measuring and predicting driver drowsiness through heart rate variability analysis. By utilizing native sensors or retrofit technology in vehicles, the company transforms physiological data into actionable insights regarding a driver's fatigue levels. This innovative approach allows for the early detection of drowsiness, enabling timely interventions to prevent accidents caused by sleepiness. With a mission centered on safety, Core for Tech aims to provide drivers with the information they need to make informed decisions about their alertness while driving.

Micropep

Series A in 2021
Micropep Technologies is an agricultural biotechnology company founded in 2016 and based in Toulouse, France. The company specializes in the development of non-GMO bioherbicides and biostimulants utilizing its innovative miPEP technology, which harnesses naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep focuses on four key development programs: germination, flowering, growth, and weed control, aiming to improve agricultural yields while maintaining the integrity of plant DNA. By leveraging the potential of these biomimetic peptides, Micropep seeks to provide effective solutions for managing plant genetics and enhancing resistance to diseases, thereby supporting sustainable farming practices.

Adionics

Seed Round in 2021
Adionics is a technology company based in Paris, France, specializing in desalination and saline water valorization. Founded in 2012, the company develops innovative solutions to selectively remove salts from brine, seawater, and other salty waters. Its flagship technology, AquaOmnes, effectively separates salt from water, while Flionex is a selective extractant composition designed for the extraction of lithium salts. Adionics focuses on providing its services to various sectors, including municipal water, power, oil and gas, and chemicals. The company is also engaged in research and development to enhance its processes, particularly in the area of lithium recycling from batteries, aiming to deliver efficient, economical solutions with minimal environmental impact.

Dessia

Series A in 2021
Dessia is a technology company that specializes in AI-augmented engineering software. Its platform employs bots to assist engineers and architects in designing mechanical systems, swiftly generating thousands of architectural configurations and optimizing them based on sustainability and profitability criteria. This streamlines the product development process, reducing lead times for automotive and mechanical engineers.

Smartway

Series A in 2021
Smartway, founded in 2012 by two brothers, is dedicated to reducing both food and non-food waste while saving consumers money. The company addresses the issue of product wastage by developing a food waste management platform that utilizes artificial intelligence to assist in-store teams in identifying items nearing their expiry dates. Smartway facilitates the recycling of these products by enabling automatic discount labeling and streamlining administrative procedures related to food donation. This creates a beneficial relationship between consumers and distributors by highlighting affordable, soon-to-expire products in nearby stores. Smartway is expanding its presence across Europe and has received multiple awards for its contributions to sustainable development and innovative solutions in mass distribution.

Zéro-Gâchis

Venture Round in 2021
Zéro-Gâchis is an innovative service to save money and avoid food waste during your shopping. The objective of Zéro-Gâchis is to reduce food waste by assisting retailers in managing unsold items. Enabling everyone to take action to reduce food waste naturally brings forth strong values that drive the team's manner of working and its constant desire to improve service efficiency.

UroMems

Series B in 2021
UroMems is a medical device company dedicated to addressing specific clinical needs related to urinary conditions that significantly impact patients' quality of life. The company specializes in the design, development, and commercialization of active implantable medical devices. Its innovative approach aims to enhance existing surgical treatments by minimizing associated side effects and ensuring that patients receive appropriate care promptly. Through its commitment to improving treatment options, UroMems seeks to benefit a wide range of patients facing urinary health challenges.

AcuSurgical

Series A in 2021
AcuSurgical is a startup focused on advancing vitreo-retinal surgery through innovative technology. The company is developing a robotic surgical assistant specifically designed for retinal microsurgery, which aims to enhance the precision of eye operations. By providing surgeons with improved tools, AcuSurgical's device addresses common challenges faced in the treatment of retinal diseases, such as age-related macular degeneration. The technology helps filter hand tremors and enhances visualization during procedures, ultimately enabling better patient outcomes in the field of ophthalmic surgery.

PowerUp

Venture Round in 2020
PowerUp Technology, founded in 2017 and based in Aulnay-Sous-Bois, France, specializes in designing and marketing advanced battery management and optimization solutions. The company focuses on providing smart chargers that optimize charging conditions based on battery temperature, charge status, and degradation levels. PowerUp's innovative solutions offer real-time monitoring of battery health, enabling effective management of battery fleets through a user-friendly web application. Their offerings are applicable across various sectors, including railway systems, specialized equipment, backup batteries, portable tools, personal vehicles, and consumer electronics. By leveraging its technology, PowerUp aims to reduce the economic and ecological costs associated with battery usage, facilitating predictive maintenance and extending the service life of batteries.

Ynsect

Series C in 2020
Ynsect is a biotechnology company based in Evry, France, that specializes in the production and processing of insects for sustainable animal feed and non-food applications. Founded in 2011, Ynsect operates insect vertical farms that convert insects into high-quality nutrition products, including proteins and lipids for livestock and pet diets. The company employs innovative bioconversion techniques to utilize organic resources, producing not only animal feed but also organic fertilizers, bioenergy, and other valuable materials. Ynsect's expertise in large-scale insect farming and automation has positioned it as a leading provider in the agro-food and environmental biotech sectors, making it a favored partner for agricultural professionals, research institutions, and investors.

Microoled

Series A in 2020
Microoled, established in 2007, specializes in the production of Active Matrix Organic Light Emitting Diode (AMOLED) displays and optical modules from its headquarters and manufacturing facility in Grenoble, France. The company caters to diverse industries including consumer electronics, medical professionals, and security sectors by offering a broad range of products for applications like video glasses, head-mounted sports devices, camera viewfinders, and professional equipment worldwide. Microoled's focus lies in resolving customer-level issues through innovative solutions that anticipate market needs.

BeFC Bioenzymatic Fuel Cells

Seed Round in 2020
BeFC Bioenzymatic Fuel Cells is a company based in Grenoble, France, that specializes in the development of ecological devices, specifically paper-based bioenzymatic fuel cells. Founded in 2020, BeFC focuses on providing sustainable and eco-friendly energy solutions aimed at minimizing environmental impact. Their innovative technology features ultra-thin, flexible, and miniature fuel cells designed to replace traditional button or coin cell batteries, which are often difficult to recycle and environmentally harmful. By offering a safe alternative, BeFC facilitates the advancement of disposable and wearable medical devices, as well as low-power applications in health monitoring, logistics, and the Internet of Things (IoT). The company's approach not only addresses existing energy needs but also opens up new opportunities in various sectors.

UroMems

Series B in 2020
UroMems is a medical device company dedicated to addressing specific clinical needs related to urinary conditions that significantly impact patients' quality of life. The company specializes in the design, development, and commercialization of active implantable medical devices. Its innovative approach aims to enhance existing surgical treatments by minimizing associated side effects and ensuring that patients receive appropriate care promptly. Through its commitment to improving treatment options, UroMems seeks to benefit a wide range of patients facing urinary health challenges.

NAWA Technologies

Venture Round in 2020
NAWA Technologies specializes in developing advanced energy storage solutions, focusing on its innovative Ultra Fast Carbon Battery Technology. Founded in April 2013 and supported by over 15 years of research and development in nanomaterials, the company aims to enhance energy conversion, storage, transport, and efficiency using carbon, which is abundant and environmentally friendly. NAWA Technologies creates ultracapacitors and battery electrodes that facilitate the integration of renewable energies into smart grids, thus promoting more efficient and sustainable electricity storage. The company is committed to minimizing the environmental impact of its manufacturing processes and emphasizes the importance of reusing, recovering, and recycling materials throughout the product lifecycle. With a dedicated team of 24 employees, NAWA Technologies operates a pilot production line to innovate new interface materials and storage devices that reduce carbon emissions and reliance on fossil fuels.

Vulkam

Series A in 2020
Vulkam SAS is a microtechnology company based in Saint-Martin-d'Hères, France, specializing in the design and production of amorphous metal parts. Founded in 2017, Vulkam focuses on creating biocompatible amorphous metal alloys primarily composed of zirconium, copper, hafnium, nickel, and titanium. The company's innovative products serve various industries, including aerospace, automotive, biomedical, and microcomponents. Vulkam's micromechanical parts are notable for their small size and exceptional strength, offering performance comparable to established industry standards. By leveraging advanced materials science, Vulkam aims to set new benchmarks in metallurgy and metal processing, catering to the growing demand for high-performance, functional components in diverse applications.

Diabeloop

Series B in 2019
Diabeloop is a medical device company based in Grenoble, France, specializing in innovative solutions for diabetes management. Founded in 2015, the company focuses on developing a closed-loop system that automates insulin delivery for individuals with type 1 diabetes. Its AI-based blood sugar monitoring device integrates a sensor that continuously measures glucose levels, a pump that administers insulin, and a smartphone application that connects these components through an embedded algorithm. This technology aims to enhance the treatment experience by reducing the mental burden on patients, allowing them to manage their condition more effortlessly and live their lives with greater freedom.

Remedee Labs

Series A in 2019
Remedee Labs SAS is a French company founded in 2016, dedicated to developing innovative solutions for chronic pain management. The company has created the Microelectronic Endorphin Trigger (MEET), a personal endorphin stimulator that facilitates on-demand stimulation of the body’s natural endorphins to alleviate pain. Drawing on a decade of pre-clinical and clinical research, Remedee Labs aims to improve the quality of life for the 1.5 billion people worldwide suffering from chronic pain, particularly focusing on conditions such as fibromyalgia. By collaborating with medical practitioners, the company offers a patient-centered digital service platform that enhances the accessibility and effectiveness of endorphin-stimulation therapy for personal healthcare. As it continues to evolve, Remedee Labs plans to expand its platform to address additional chronic pain conditions, positioning itself as a leader in neuromodulation technology for pain management.

Cailabs

Series B in 2019
CAILabs SAS is a French deep tech company headquartered in Rennes, specializing in the design, development, and production of photonic solutions aimed at optimizing light utilization in various applications. Established in 2013, CAILabs focuses on innovative optical components, particularly through its patented Multi-Plane Light Conversion (MPLC) technology. The company provides a range of products, including mode multiplexers, light converters, and laser beam shaping solutions tailored for the telecommunications and industrial laser sectors. Its offerings are designed to enhance the performance of fiber optic networks and laser material processing, addressing critical challenges such as atmospheric turbulence and the need for efficient signal multiplexing. CAILabs aims to leverage its expertise and technological innovations to create reliable and cost-effective solutions for clients in the photonics industry.

Scintil Photonics

Seed Round in 2019
Scintil Photonics SAS is a company based in Grenoble, France, that specializes in the development of silicon photonic integrated circuits. Founded in 2018, the company offers a range of products, including laser integration, multi-wavelength lasers, waveguides, wavelength filters, and photodetectors. Scintil Photonics employs a unique approach by combining silicon and indium phosphide materials through wafer-scale bonding, utilizing commercial silicon foundry processes to create fully integrated photonic circuits. These circuits are designed to enhance high-speed optical communications and chip interconnections, providing a single-chip solution that integrates optical amplifiers and lasers with silicon modulators and germanium photodetectors. This innovative technology improves performance and reliability while significantly reducing implementation costs across various industries.

Keranova

Venture Round in 2019
Keranova S.A., founded in 2015 and based in Saint Etienne, France, with an additional office in Vénissieux, specializes in the design and development of innovative surgical equipment for ophthalmologic procedures, specifically targeting the anterior segment of the eye. The company focuses on creating advanced surgical instruments that utilize a unique patented technology to enhance the efficiency and accuracy of ophthalmic surgeries. By introducing automation into these procedures, Keranova aims to reduce the reliance on manual techniques, offering equipment equipped with vision systems, intelligent software, and precise robotic movements. This approach represents a significant advancement in ophthalmic surgery, allowing for more reproducible outcomes and improved patient care.

Robocath

Venture Round in 2019
Robocath, founded in 2009 by Philippe Bencteux, MD, specializes in the design, development, and commercialization of robotic solutions for treating cardiovascular diseases. The company is a prominent player in the medical robotics industry, focusing on enhancing the safety and efficacy of medical procedures through innovative technology. Its flagship product, R-One™, is a robotic system specifically engineered for coronary angioplasty, optimizing safety and precision during interventions. R-One™ offers a unique open architecture that ensures compatibility with leading medical devices and catheterization laboratories, facilitating improved procedural conditions. Robocath aims to establish itself as a leader in vascular robotics while advancing the remote treatment of vascular emergencies, thereby ensuring optimal care pathways for patients.

Traxens

Series C in 2019
Traxens is a provider of supply chain tracking services that offers comprehensive data and analytics to enhance visibility into container transport and logistics. The company focuses on delivering precise and timely information on containers and their transporters, enabling stakeholders in multi-modal transport to improve operational efficiency, reduce costs, and optimize investments. Through a dedicated three-year research and development program, Traxens has developed advanced technology for cost-effective, durable, and autonomous devices capable of capturing and transmitting real-time data from anywhere in the world. This innovative approach allows Traxens to transform logistics data into actionable insights, benefiting a wide range of customers in the supply chain industry.

Microphyt

Venture Round in 2019
Microphyt is a company focused on researching, developing, producing, and marketing natural algae-based products. It specializes in creating bioactive dietary supplements aimed at promoting weight loss and supporting brain health. The company utilizes an industrial-scale supply of microalgae biomass and extracts, ensuring the preservation of cell integrity while achieving commercial quantities of slow-growing or biofilm-forming species. This approach enables Microphyt to effectively cater to the demands of healthcare industries, particularly in the personal care and food sectors.

NAWA Technologies

Venture Round in 2019
NAWA Technologies specializes in developing advanced energy storage solutions, focusing on its innovative Ultra Fast Carbon Battery Technology. Founded in April 2013 and supported by over 15 years of research and development in nanomaterials, the company aims to enhance energy conversion, storage, transport, and efficiency using carbon, which is abundant and environmentally friendly. NAWA Technologies creates ultracapacitors and battery electrodes that facilitate the integration of renewable energies into smart grids, thus promoting more efficient and sustainable electricity storage. The company is committed to minimizing the environmental impact of its manufacturing processes and emphasizes the importance of reusing, recovering, and recycling materials throughout the product lifecycle. With a dedicated team of 24 employees, NAWA Technologies operates a pilot production line to innovate new interface materials and storage devices that reduce carbon emissions and reliance on fossil fuels.

NH TherAguix

Series A in 2019
NH TherAguix SAS is a clinical-stage pharmaceutical company based in Villeurbanne, France, focused on the development of nanomedicines for cancer treatment. The company specializes in creating innovative therapeutics that enhance radiotherapy for solid tumors. Its lead product, AGuIX, is a theranostic nanoparticle designed to improve the localization of tumors and optimize radiation therapy outcomes. By facilitating intravenous administration, AGuIX enables healthcare professionals to determine the best timing for irradiation, targets tumor tissues more effectively, and minimizes adverse effects on healthy tissues by reducing radiation doses. Founded in 2015, NH TherAguix is dedicated to advancing cancer treatment through its pioneering approach to combining imaging and radiotherapy.

Diota

Series B in 2019
Diota is a company based in Massy, France, specializing in augmented reality (AR) software solutions tailored for industrial applications. Founded in 2009, the company focuses on integrating digital data with human operators to enhance the efficiency of complex industrial processes. Its flagship product, DiotaPlayer, facilitates the use of AR across various industrial sectors, including manufacturing, aerospace, automotive, and oil and gas. The software allows users to browse, interact with, check, report, and track information seamlessly within existing hardware and software environments. Diota’s solutions are compatible with multiple devices, such as tablets and head-mounted displays, making them versatile for different operational needs. Additionally, the company offers consulting, technical support, and training services to optimize the implementation of its technologies. Diota's client base includes major industry players such as Safran Group, Dassault Aviation, and Renault, positioning it as a key contributor to the digital transformation of the industrial landscape in Europe.

Carthera

Series B in 2018
Carthera is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices for treating brain disorders. Its proprietary device, SonoCloud®, is an intracranial ultrasound implant that, when used in conjunction with an intravenous microbubble agent, temporarily opens the blood-brain barrier. This mechanism significantly enhances the delivery of therapeutic molecules to the brain, potentially providing new treatment options for debilitating neurological conditions. Through its technology, Carthera aims to enable healthcare professionals to address challenging brain disorders more effectively.

Blue Valet

Venture Round in 2018
Blue Valet, founded in 2015 and based in Mérignac, France, specializes in online valet parking services at airports and train stations. The company offers a convenient platform for travelers to book valet services, ensuring a hassle-free experience when accessing major mobility hubs. Blue Valet aims to provide an economical and efficient solution for both leisure and business travelers, allowing them to navigate their journeys without stress or complications.

iskn

Venture Round in 2018
iskn is a consumer electronics company that develops and markets the slate for smart drawing. iskn is the leading pioneer in AUGMENTED INTERACTION thanks to its technology representing 24 international patents based on 60 years of deep tech R&D expertise in magnetometry at the world-renowned CEA LETI. The company’s primary mission consists in enriching the experience and facilitate interaction with the digital world by bringing back emotion through the use of day-to-day physical objects. This has already come to life by turning any pencil into a digital one with the widely adopted SLATE, and the yet to come disruptive REPAPER graphic tablet.

Terakalis

Seed Round in 2018
Terakalis is a company that specializes in the development of non-destructive testing equipment for the analysis and control of materials and industrial processes. Established through a technological partnership with the Charles Coulomb laboratory in 2012, Terakalis focuses on TeraHertz electromagnetic waves, which range from 100 GHz to 10 THz. The company's offerings include a variety of both generic and custom-made products and systems designed to inspect materials for internal defects and to characterize their physical and chemical properties. By providing integrated line-of-production equipment and portable alternatives, Terakalis enhances operational efficiency for businesses across various sectors.

Prophesee

Series B in 2018
Prophesee SA, founded in 2014 and based in Paris, France, specializes in developing advanced machine vision sensors and systems. Renowned for its neuromorphic vision technology, the company has created a unique visual processing platform that mimics human vision by detecting events rather than capturing sequences of images. This innovative Metavision® approach enables significant advancements in speed, dynamic range, data efficiency, and power consumption, making it suitable for a variety of applications including autonomous driving, mobile devices, industrial automation, and security systems. Prophesee serves a diverse clientele across multiple sectors such as biomedical, gaming, robotics, and aerospace. The company boasts a team of over 100 engineers and holds more than 50 international patents, positioning itself as a leader in next-generation vision technologies.

mirSense

Seed Round in 2018
mirSense SA is a French company specializing in the development and manufacturing of Quantum Cascade Lasers (QCL) and QCL-based spectrometer modules. Established in 2015 and headquartered in Palaiseau, the company offers a range of products including uniMir, a single mode QCL for high spectral purity; multiMir, a semiconductor solution for broadband tuning; multiSense, a spectrometer module designed for gas analyzer manufacturers; and powerMir, power lasers tailored for defense and security applications. These technologies are aimed at enhancing air quality, reducing greenhouse gas emissions, ensuring process sustainability, and improving the accuracy of medical treatments. By providing ultra-compact gas sensors with very low detection limits, mirSense supports industries and defense sectors in monitoring gas emissions, detecting hazardous substances, and analyzing biological samples with affordability and high performance.

En Voiture Simone

Venture Round in 2018
En Voiture Simone is an online driving school that launched in 2015, dedicated to connecting students with qualified driving instructors. The platform allows learners to find instructors who meet their specific needs, facilitating a personalized and effective learning experience for obtaining a driving license. By leveraging technology, En Voiture Simone aims to simplify the process of finding the right driving instructor, thus supporting students in achieving their driving goals.

Aledia

Series C in 2018
Aledia SA, established in 2011, specializes in the development and manufacturing of light-emitting diodes (LEDs). The company's proprietary technology involves a 3D architecture using gallium-nitride-on-silicon microwires, enabling cost-effective production of LED chips at 25% the cost of traditional planar LED chips. Aledia's products cater to general lighting, automotive, and display applications, with a focus on mobile displays and microdisplays for AR/VR devices. Headquartered in Grenoble, France, the company has subsidiaries in Malacca, Malaysia, and Palo Alto, California.

UPMEM

Seed Round in 2017
UPMEM is a fabless semiconductor company focused on enhancing the performance of data-intensive applications through its innovative Processing-In-Memory (PIM) technology. By integrating a large number of programmable co-processors directly next to data storage, UPMEM's solution significantly accelerates data processing tasks, achieving performance improvements of over ten times compared to traditional server architectures. This technology addresses the limitations imposed by data movement in data centers, making it particularly effective for analytics and artificial intelligence applications. UPMEM's platform not only reduces off-chip data movements but also contributes to lower energy consumption and a smaller hardware footprint, making it an attractive option for leading global application developers and cloud service providers.

SeqOne Genomics

SeqOne S.A.S. is a company based in Montpellier, France, that specializes in developing genomic data analysis software for the healthcare industry. Founded in 2017, SeqOne's platform offers end-to-end management of next-generation sequencing (NGS) and bioinformatics data, providing advanced tools for analyzing complex genomic information. The software is designed to deliver medically actionable results across various areas, including oncology, hematological diseases, rare diseases, genetic screening, and hereditary conditions. By addressing the challenges associated with analyzing rich genomic data, SeqOne aims to enhance the accessibility and effectiveness of genomic medicine, thereby facilitating improved treatment options for patients. The company serves both private and public healthcare sectors, contributing to the ongoing transformation of healthcare through the integration of genomic insights.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.